Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.073 | 0.09 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |